Investors eyes growth in biotechnology
IPE-QUEST - A continental European investor is looking to hire a manager to look after a $20m (€15.2m) biotechnology equity mandate, using IPE-Quest.
Details of QN1017 reveal the investor is keen to find a manager who can deliver an active all/large-caps global developed markets equity offering focused specifically on the biotechnology market, and benchmarked either to the Nasdaq Biotechnology or the MSCI Wold Biotechnology indices.
The successful applicant will be allowed to operate within a 1-10% tracking error but must demonstrate "in-depth sector know-how and research capabilities" of the biotechnology sector and deliver "active management with bottom-up stock selection in innovative biotechnology companies" to achieve returns above the sector average.
Performance must be stated to 31 March 2009, net of fees, and the minimum track record in this space is four years, though seven years would be preferable to the investor.
Closing date for applications is 1 May 2009.